CASI: Gunggung dhuwit awis saben saham CASI Pharmaceuticals, Inc.

Lambang korporat lan logo CASI Pharmaceuticals Inc. (CASI)

The trend in cash per share indicates pressure stemming from testing costs and sales delays. CASI Pharmaceuticals is driving innovation in China through partnerships with foreign laboratories, yet faces intense pressure from global players and the risk of technological obsolescence. Meanwhile, the level of 0.00 represents the current value of this financial metric.

CASI (casipharmaceuticals.com) riwayat Dhuwit awis saben saham saka 04.07.2022 nganti 14.03.2026

Rincian analitis perusahaan CASI Pharmaceuticals

- nilai pasar lan prakiraan target analis:
- informasi kapitalisasi pasar:
- rincian posisi dhuwit lan arus kas:
Analisis komprehensif perusahaan:CASI CASI Pharmaceuticals, Inc.
Barang utama CASI Pharmaceuticals

The market evaluates the potential of CASI Pharmaceuticals through the lens of available resources for expansion. The indicator is calculated as the ratio of total liquid assets to the number of shares outstanding. By analyzing the current liquidity per share, an investor can see the real value of reserves without accounting distortions. A decline in this metric signals either capital dilution or investments in expanding the oncology ecosystem in China. This is a critical marker of financial stability when integrating Western drugs.